Sabrient Systems Releases Annual Stock Picks for 2013

The Baker’s Dozen 2012 Portfolio Gained 43% Across the Last 12 Months

Santa Barbara, Calif. – Jan. 11, 2013 – Sabrient Systems, LLC, an independent equity research firm that specializes in alpha extraction through quantitative and qualitative analysis, announced today the release of its annual Baker’s Dozen, 13 top-ranked stocks that are expected to outperform their peers in 2013. 

The Baker’s Dozen initiative has outperformed the S&P 500 Index by an annualized average of nearly +12% and this year marks the fifth anniversary for the list. According to year-to-date performance tracking on Dark-liquidiy.com, Sabrient outperformed industry peer stock picks by nearly 20%. Most recently, the 2012 Baker’s Dozen portfolio gained 43%, including two triple-digit gains and six double-digit performers. The 2013 stocks include:

Genworth Financial Inc. (GNW), Ocwen Financial Corporation (OCN), NXP Semiconductors (NXPI), IAC/InterActiveCorp (IACI), Alaska Air Group Inc. (ALK), Marathon Petroleum Corp. (MPC), Air Lease Corp. (AL), EPL Oil & Gas Inc. (EPL), Manitowoc Co. (MTW), Express Scripts Holding Co. (ESRX), Ashland Inc. (ASH), Seagate Technology Inc. (STX), Jazz Pharmaceuticals PLC (JAZZ).

“Even during volatile markets, the Baker’s Dozen has continued to thrive which can be attributed to the proprietary research methodology we use to ensure multiple factors are examined and considered when creating this annual list,” said David Brown, Chief Market Strategist for Sabrient Systems. “We believe in a strong, diversified approach in order to stay competitive in the marketplace.”

By leveraging its proprietary Earnings Quality Rank, Sabrient Systems, in combination with Gradient Analytics, review a company’s relative potential risk arising out of accrual accounting practices to ensure quality picks for the annual stock recommendations.

“Each year, we use Sabrient's award-winning quantitative ranking system to identify top-ranked stocks that exhibit strong growth at a reasonable price as basis for the Baker’s Dozen,” said Scott Brown, President at Sabrient Systems. “We leverage our unbiased, fundamentals-based, quantitative approach to create a short list of high-quality stocks, which take into account additional factors such as current news, in order to provide our clients with a diverse list that covers a variety of sectors.”

The top 13 stocks are chosen from 2,200 eligible names comprising a diverse cross-section of sectors and industries. Download the video to learn more about the 2013 Baker’s Dozen and the analysis behind the picks.

#          #          #

PRESS CONTACT:

Cognito
Caitlin Mitchell
+1 646.395.6300
sabrient@cognitomedia.com

 

ABOUT SABRIENT SYSTEMS, LLC

---------------------------------------------
Sabrient Systems, LLC specializes in unbiased, fundamentals-based quantitative equity research for the benefit of investment professionals, hedge funds, and self-directed investors. The firm analyzes nearly 5,000 U.S. and 500 Canadian traded stocks and identifies those that appear poised to out-perform or under-perform the market. Sabrient first published rankings in 2002, and its models have consistently outperformed relevant benchmarks over a broad range of investing styles, market caps, time frames and market conditions. Sabrient is based in Santa Barbara, California. Visit www.sabrient.com.

---------------------------------------------

ABOUT GRADIENT ANALYTICS

Founded in 1996, Gradient Analytics provides qualitative research for identifying long and short ideas and reducing stock-specific risk. Gradient's rigorous research methods are based on academic and proprietary studies in the areas of quality of earnings and corporate executive behavior. As part of Sabrient, Gradient Analytics includes:

  • Earnings Quality Analytics (U.S.)—comprehensive forensic-accounting, financial-statement, and corporate-governance analysis of widely held public companies.
  • Equity Incentive Analytics (U.S.)—actionable investment ideas based on the relationship between future earnings/stock-price performance and abnormal executive stock dispositions and stock-option behavior, as well as the relationship between performance and equity-incentive plan design
  • Gradient International (non-U.S.)—in-depth research of forensic-accounting issues, foreign-exchange effects, domiciled market reporting and disclosure anomalies, valuation in light of sustainable earnings and balance-sheet robustness, corporate governance and executive behavior.